- Zacks•last month
Nymox (NYMX) announced positive results from the seven-year, prospective, placebo-controlled, double-blind study on fexapotide (NX-1207).
- Insider Monkey•last month
In a marked reversal, crude futures are off 1.4% today after a disappointing EIA report, while the broader indexes are each higher as traders await the ‘Brexit’ outcome tomorrow. Among the stocks showing more volatility than the indexes are MBIA Inc. (NYSE:MBI), Emergent Biosolutions Inc (NYSE:EBS), Inovio Pharmaceuticals Inc (NASDAQ:INO), Fitbit Inc (NYSE:FIT), and Nymox Pharmaceutical Corporation […]
Nymox Pharmaceutical CorporationNasdaqCM
|Bid||4.01 x 2500|
|Ask||4.04 x 100|
|52wk Range||1.79 - 4.37|
|Day's Range||3.95 - 4.14|
|Avg Vol (3m)||244,077|
As of 2:48 PM EDT. NasdaqCM Real Time Price. Market open.